Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-16-011108
Filing Date
2016-02-16
Accepted
2016-02-16 16:06:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7044236_sc13g-a1.htm SC 13G/A 107434
  Complete submission text file 0000919574-16-011108.txt   109256
Mailing Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019
Business Address 157 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019 212-333-0100
KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by) CIK: 0001000097 (see all company filings)

EIN.: 134015739 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006
Business Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006 212-269-2834
Dipexium Pharmaceuticals, Inc. (Subject) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88072 | Film No.: 161428061
SIC: 2834 Pharmaceutical Preparations